Yan Xiao, Jinwei Wang, Kai Yang, Meiling Jiang, Bo Zhang
{"title":"SARS-CoV-2诱导化疗耐药B细胞非霍奇金淋巴瘤缓解：病例报告","authors":"Yan Xiao, Jinwei Wang, Kai Yang, Meiling Jiang, Bo Zhang","doi":"10.1159/000541964","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Investigation on virus-host interaction may provide new clues for antitumor immunotherapy.</p><p><strong>Case presentation: </strong>In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission.</p><p><strong>Conclusion: </strong>Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based antitumor immune therapy in the future.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1273-1276"},"PeriodicalIF":0.7000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542925/pdf/","citationCount":"0","resultStr":"{\"title\":\"SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report.\",\"authors\":\"Yan Xiao, Jinwei Wang, Kai Yang, Meiling Jiang, Bo Zhang\",\"doi\":\"10.1159/000541964\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Investigation on virus-host interaction may provide new clues for antitumor immunotherapy.</p><p><strong>Case presentation: </strong>In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission.</p><p><strong>Conclusion: </strong>Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based antitumor immune therapy in the future.</p>\",\"PeriodicalId\":9625,\"journal\":{\"name\":\"Case Reports in Oncology\",\"volume\":\"17 1\",\"pages\":\"1273-1276\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542925/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000541964\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000541964","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
导言：研究病毒与宿主的相互作用可为抗肿瘤免疫疗法提供新线索：研究病毒与宿主的相互作用可为抗肿瘤免疫疗法提供新线索：在本病例报告中，我们描述了一例不寻常的B细胞非霍奇金淋巴瘤病例，患者是一名老年妇女，感染SARS-COV-2后康复。我们对该病例进行了讨论，并认为病毒诱导的针对肿瘤的交叉反应是导致病情缓解的原因：结论：绘制 B 细胞非霍奇金淋巴瘤抗原和 SARS-COV-2 抗原的表位特征图，可为今后基于抗原的抗肿瘤免疫疗法提供急需的信息。
SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report.
Introduction: Investigation on virus-host interaction may provide new clues for antitumor immunotherapy.
Case presentation: In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission.
Conclusion: Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based antitumor immune therapy in the future.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
